First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization

Center for Reproductive Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Fertility and Sterility (Impact Factor: 4.59). 04/2003; 79(3):621-3. DOI: 10.1016/S0015-0282(02)04804-5
Source: PubMed

ABSTRACT To report the first pregnancy and live birth after ovarian stimulation using a chimeric long-acting human recombinant FSH agonist (recFSH-CTP) for IVF.
Case report.
Tertiary fertility center.
A 32-year-old woman with a 7-year history of primary infertility.
Ovarian stimulation with a single SC injection of 180 microg recFSH-CTP on cycle day 3, followed by daily injections of 150 IU recFSH from cycle day 10 onward, combined with daily GnRH antagonist 0.25 mg SC to prevent a premature LH rise. Final oocyte maturation was induced by 10,000 IU hCG.
First ongoing pregnancy obtained with recFSH-CTP.
Twelve oocytes were retrieved. Ten oocytes were fertilized in vitro by intracytoplasmic sperm injection, and from these 10 oocytes, two embryos were subsequently transferred after 3 days of culture. A pregnancy test 2 weeks after ET was positive, and ultrasound investigation revealed an intact, intrauterine, singleton pregnancy after 12 weeks.
The first pregnancy and live birth was achieved after ovarian stimulation using recFSH-CTP for IVF.

  • Source
    • "A study in healthy female volunteers showed that a single dose of rFSH-CTP induced multiple follicular growth accompanied by a dose-dependent rise in serum inhibin-B (Duijkers et al., 2002). The first live birth after ovarian stimulation using a chimeric long-acting human rFSH agonist (rFSH-CTP) was reported by Beckers et al. (2003). Ovarian stimulation was initiated on day 3 of a spontaneous menstrual cycle with 180 mg rFSH-CTP. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The 20th century witnessed the steady development of knowledge about the reproductive process in animals and humans. These advances led to the identification of higher centres governing the dynamics of ovarian function and to the discovery of gonadotrophic hormones. As the mechanisms of action of these hormones became increasingly understood, they began to be used in the management of infertility during the early 1930s. Hormone extracts were originally prepared from animal pituitaries and pregnant mare serum, as well as from human pituitaries, placenta and urine, with pregnancies reported following their use in the late 1930s. This review traces the constant quest to reduce risks and improve safety and efficacy of hormone preparations for patients. It describes the complex path and perils leading to the pure hormone preparations that are available today, concluding with an optimistic glimpse towards the future. Small molecules that are orally active and specific are currently being investigated, some with the capacity to bypass many parts of the receptor conformation. Here lies the immediate future of this field, utilizing low-cost, small, defined molecules to stimulate follicle growth, ovulation and corpus luteum formation. Perhaps one day the classical gonadotrophins will no longer be required in clinical treatment.
    Human Reproduction Update 09/2004; 10(6):453-67. DOI:10.1093/humupd/dmh044 · 8.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ovulation induction has developed as a valuable noninvasive therapy for the infertile couple. The nurse's role focuses on assisting the couple, as a unit, to understand and cope with the necessary regimen, tests, examinations, and therapies necessary to reach the goal of conception. The physiologic regulation of the menstrual cycle, current pharmacologic therapy, treatment protocols, and the unique role of the infertility nurse are reviewed.
    Journal of Obstetric Gynecologic & Neonatal Nursing 11/1985; 14(s6). DOI:10.1111/j.1552-6909.1985.tb02798.x · 1.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper reports results for uncertainties obtained from a Monte Carlo simulation of noise-parameter measurements. The simulator permits the computation of the dependence of the uncertainty in the noise parameters on uncertainties in the underlying quantities. Results have been obtained for the effect due to uncertainties in the reflection coefficients of the input terminations, the noise temperature of the hot noise source, connector variability, the ambient temperature, and the measurement of the output noise. Representative results are presented for both uncorrelated and correlated uncertainties in the underlying quantities
    Microwave Symposium Digest, 2002 IEEE MTT-S International; 02/2002
Show more